Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
So lately we’ve been seeing ads for this birth-control pill called Yasmin, and even though it’s been for sale under that name, particularly in Europe, for some time, it strikes us as a really peculiar name for that kind of drug. (The FDA is thinking of approving it in the U.S. in a low-dose version, which is bound to spur more advertising—and broader brand recognition for the product—in late 2005.)
We get the idea here. Women want to have warm and fuzzy associations with their birth-control pills, to make it seem less like they’re taking a prescription drug.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in